Zioptan Solution/ Drops
Product Images NDC 82584-609

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zioptan (NDC 82584-609). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Thea Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zioptan 01)

Chemical Structure (Zioptan 01)
Chemical structure of tafluprost, the active ingredient in ZIOPTAN ophthalmic solution 0.015 mg/mL from Thea Pharma Inc.*
FDA Label Image

Figure A (Zioptan 02)

Figure A (Zioptan 02)
An illustration showing a hand holding a single-use vial of ophthalmic solution, intended for dispensing drops. The vial is small, with a narrow neck and a breakable top to access the liquid inside. This image likely demonstrates the correct handling or preparation of the solution for eye administration.*
FDA Label Image

Figure B (Zioptan 03)

Figure B (Zioptan 03)
An instructional illustration showing two hands manipulating a small ophthalmic dropper bottle, with one hand stabilizing the bottle and the other hand twisting or removing the cap. This image likely demonstrates proper handling or opening of an eye drop solution container.*
FDA Label Image

Figure C (Zioptan 04)

Figure C (Zioptan 04)
An instructional illustration showing a person administering ophthalmic solution drops into the eye using a dropper. The image emphasizes correct eye drop instillation technique.*
FDA Label Image

Figure D (Zioptan 05)

Figure D (Zioptan 05)
Illustration showing a person applying ophthalmic solution drops to their eye using a dropper. The image demonstrates the proper technique for administering eye drops by holding the dropper above the eye while pulling down the lower eyelid.*
FDA Label Image

Principal Display Panel (0.3 mL Container Pouch Carton)

Principal Display Panel (0.3 mL Container Pouch Carton)
Packaging label for ZIOPTAN 0.0015% (tafluprost ophthalmic solution), an ophthalmic solution supplied as single-use preservative-free, sterile containers. The label indicates refrigeration storage, topical application in the eye, and a package size of 30 single-use containers (3 pouches x 10 per pouch, 0.3 mL each). Manufactured for Thea Pharma Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.